China National Accord Medicines (SZSE:000028) Long-Term Debt : ¥0 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines Long-Term Debt?

China National Accord Medicines's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥0 Mil.

China National Accord Medicines's annual Long-Term Debt declined from Dec. 2021 (¥72 Mil) to Dec. 2022 (¥18 Mil) and declined from Dec. 2022 (¥18 Mil) to Dec. 2023 (¥0 Mil).

China National Accord Medicines Long-Term Debt Historical Data

The historical data trend for China National Accord Medicines's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Long-Term Debt Chart

China National Accord Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

31.64

71.64

17.50

China National Accord Medicines Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															17.00	9.50	-	-	-

China National Accord Medicines (SZSE:000028) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

China National Accord Medicines Long-Term Debt Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

200028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

Executives

Su Wei Wei	Independent director
Chen Chang Bing	Secretary Dong
Peng Juan	Director
Fu Ming Zhong	Director

China National Accord Medicines Headlines

No Headlines